| Name | Title | Contact Details |
|---|
Hospira is the world`s leading provider of injectable drugs and infusion technologies. Through our broad, integrated portfolio, we are uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. Through our offering of high-quality, lower-cost generic medications, we continue to help reduce the overall costs of healthcare — to improve both the affordability of care for patients and the financial strength of the global healthcare system. By working with our device customers to integrate technologies at the point of care, we are the partner of choice for improving patient and caregiver safety, clinical outcomes, cost management, as well as caregiver efficiency and effectiveness. Additionally, our One2One™ business is a leading provider of contract manufacturing services to proprietary pharmaceutical and biotechnology companies for formulation development, filling and finishing of injectable pharmaceuticals. At Hospira, we have the opportunity to Make a Difference every day by positively impacting the lives of our customers and patients and delivering value to all of our stakeholders.
Argen is the largest dental gold producer in the world and the USA. Argen started as a small business with a focus on complete customer satisfaction. Although the business has grown significantly over the years, our personal touch and customer service are unmatched in the marketplace, and we pride ourselves on being the benchmark for unsurpassed quality.
Noesis Health is a Lynn Haven, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Bard Peripheral Vascular Inc is a Tempe, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
RF Surgical Systems, Inc. is a medical device company with headquarters in Bellevue, Washington and engineering R & D facilities in San Diego, California. The advanced technologies used in the RF Surgical Detection System are protected by U.S. patents. Regulatory clearance to market the system was granted by the U.S. Food and Drug Administration in November of 2006